Skip to content

Author

Jason A. Greenbaum

We have 5 of 26 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Enrichment of CD4−CD8− cytotoxic Vδ1/3 T cells in pulmonary tuberculosis disease

This study used single-cell RNA sequencing to provide a high-resolution characterization of CD4−CD8− γδ T cells in peripheral blood across healthy Mtb-(non-)sensitized and TB disease pre-/post-treatment cohorts and found an activated and cytotoxic gene signature in γδ T cells of TB disease compared with both healthy co...

Kendall Kearns, R. Tippalagama, Ashu Chawla et al. · 0 citations
Open access Aug 2026

An Open Benchmark for Systems Vaccinology: Insights from the CMI-PB Challenges

Pre-existing antigen-specific antibody titers and baseline monocyte frequencies are identified as the most consistent predictors of post-vaccination immunity, highlighting the dominant role of individual immune setpoints.

Pramod Shinde, Lisa Willemsen, Jiyeun Lee et al. · 0 citations
Open access Aug 2026

Identification of pre-existing ubiquitous neoantigen-reactive tumor-infiltrating T-cells in a patient with metastatic pancreatic neuroendocrine tumor

Direct evidence is provided that a single ubiquitous mutation-derived neoantigen can generate systemic T-cell responses and clonotype expansion across multiple metastatic sites in a TMB-low, TIL-low tumor.

J. Tanis, Katy J. McCann, F. E. Castañeda-Castro et al. · 0 citations
Review Open access Aug 2026

The Cancer Epitope Database and Analysis Resource (CEDAR): current capabilities and future directions

CEDAR’s current capabilities, report on progress in curation, database development, and tool availability, and outline the opportunities and challenges ahead for expanding its scope and utility to the cancer research community are described.

Zeynep Koşaloğlu-Yalçın, Ibel Carri, Daniel Marrama et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.